TECH as of Oct 31 · 15:22 ET
TECHNasdaqBiological Products, (No Diagnostic Substances)
Bio-Techne Corp · Brief
Next report
4 days
Nov 4 · before openest.Q1 FY27
Expected move
Inputs2 of 7≥ implied
- avg implied
- ±9.0%
- avg realized
- ±6.7%
Oct 30 '24±8.1%▲+7.46%×0.92
Feb 5 '25±6.8%▲+3.72%×0.54
May 7 '25±9.7%▲+2.16%×0.22
Aug 6 '25±8.6%▼−8.73%×1.01
Nov 5 '25±11.1%▼−1.90%×0.17
Q2 FY26±10.0%▲+6.25%×0.62
Q3 FY26±8.8%▼−16.36%×1.86
Q4 FY26—▲+0.11%—
quarterimplied−20%0+20%realized×
Q4 FY26—▲+0.11%—
Q3 FY26±8.8%▼−16.36%×1.86
Q2 FY26±10.0%▲+6.25%×0.62
Nov '25±11.1%▼−1.90%×0.17
Aug '25±8.6%▼−8.73%×1.01
May '25±9.7%▲+2.16%×0.22
2 older reports
Feb '25±6.8%▲+3.72%×0.54
Oct '24±8.1%▲+7.46%×0.92
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 4 report · est.Bull2 of 3
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
TECH report sessionSuppliers 1
Customers 1
× = co-movement · max 501dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.